Zions Bancorporation’s Editas Medicine EDIT Stock Holding History

Zions Bancorporation’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-200	Closed	-$5K	–	981
2019 Q2	$5K	Hold	200	–	–	﹤0.01%	726
2019 Q1	$5K	Hold	200	–	–	﹤0.01%	766
2018 Q4	$5K	Hold	200	–	–	﹤0.01%	379
2018 Q3	$6K	Sell	200 -200	-50%	-$6.46K	﹤0.01%	612
2018 Q2	$14K	Hold	400	–	–	0.01%	308
2018 Q1	$13K	Hold	400	–	–	﹤0.01%	389
2017 Q4	$12K	Buy	+400	New	+$10.1K	﹤0.01%	453

Other funds holding EDIT

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zions Bancorporation's EDIT Position: Q3 2019 in Review

Zions Bancorporation sold out of Editas Medicine (EDIT) in Q3 2019, closing a stake of 200 shares — an estimated $5K sold.

Zions Bancorporation first reported a position in EDIT in Q4 2017 and held it in 7 quarters. The position peaked at $14K in Q2 2018. 187 funds tracked by Wall St. Rank hold EDIT as of Q3 2019.

Zions Bancorporation reported no remaining Editas Medicine position as of Q3 2019 after selling out during the quarter.
Zions Bancorporation sold 200 Editas Medicine shares in Q3 2019, an estimated $5K.
Zions Bancorporation first reported a position in Editas Medicine in Q4 2017 and held it in 7 quarters.
Zions Bancorporation's Editas Medicine position peaked at $14K in Q2 2018.
187 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2019.

Based on Zions Bancorporation's 13F filing for Q3 2019, filed 13 Nov 2019.